ARVN Competitors & Alternatives

Compare Arvinas Inc with similar stocks in the same industry

Biotechnology

ARVN

Main Stock
$6.78
-0.59%
Tradestie Score
54
Market Cap
$670.30M
Revenue Growth
-98.8%
Analyst Upside
+106.5%

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
XOMA XOMA Royalty Corporation Common Stock
$40.17
-9.16%
$474.20M 28.2 46 Compare
ABSI Absci Corporation Common Stock
$7.73
-8.58%
$468.01M - 44 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$9.11
-2.77%
$463.20M - 44 Compare
SLDB Solid Biosciences Inc. Common Stock
$6.56
-4.17%
$457.09M - 37 Compare
MRVI Maravai LifeSciences Holdings, Inc. Class A Common Stock
$7.46
-1.06%
$454.29M - 55 Compare
RAPT RAPT Therapeutics, Inc. Common Stock
$58.02
+0.07%
$450.49M - 50 Compare
MLTX MoonLake Immunotherapeutics Class A Ordinary Shares
$11.94
-4.52%
$448.32M - 33 Compare
ATXS Astria Therapeutics, Inc. Common Stock
$12.58
+0.64%
$425.52M - 54 Compare
ALMS Alumis Inc. Common Stock
$5.06
-9.65%
$422.50M - 43 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$11.65
-4.74%
$407.71M - 52 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry